We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

QUAD:NYSEQuad Graphics, Inc Analysis

Data as of 2026-05-19 - not real-time

$7.33

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Quad/Graphics is trading around $7.33, comfortably above its 20‑day SMA of $7.55 and the 50‑day SMA of $7.14, which signals a short‑term bullish bias despite a bearish MACD histogram. RSI sits near 49, suggesting the stock is neither overbought nor oversold, while the 30‑day volatility of roughly 64% and a beta under 1 point to moderate price swings. The company posted a modest Q1 profit of $6.2 million and reaffirmed its full‑year guidance, but revenue is down 7.7% year‑over‑year, highlighting a challenging top‑line environment. Dividend yield remains attractive at 5.46%, with a payout ratio of about 56%, though the balance sheet shows a high debt‑to‑equity ratio exceeding 390, raising questions about long‑term financial flexibility. The DCF‑derived fair value of $6.46 sits below the current market price, implying the stock is currently priced above intrinsic expectations. Overall, Quad/Graphics offers a solid dividend and modest valuation relative to industry PE, but growth constraints and leverage temper enthusiasm.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above short‑term moving averages but MACD turning bearish
  • Neutral RSI and high near‑term volatility
  • Strong dividend yield supporting price floor

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Attractive dividend yield with sustainable payout
  • Valuation below industry average PE
  • Bullish trend direction despite modest earnings growth

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Elevated debt‑to‑equity ratio limiting financial flexibility
  • Revenue contraction and low operating margins
  • Potential upside if the company successfully diversifies beyond print

Key Metrics & Analysis

Financial Health

Revenue Growth-7.70%
Profit Margin1.16%
P/E Ratio12.6
ROE25.61%
ROA5.31%
Debt/Equity398.02
P/B Ratio2.9
Op. Cash Flow$91.2M
Free Cash Flow$64.0M
Industry P/E29.5

Technical Analysis

TrendBullish
RSI48.8
Support$6.85
Resistance$8.64
MA 20$7.55
MA 50$7.14
MA 200$6.43
MACDBearish
VolumeDecreasing
Fear & Greed Index89.59

Valuation

Fair Value$6.46
Target Price$9.93
Upside/Downside35.52%
GradeOvervalued
TypeValue
Dividend Yield5.46%

Risk Assessment

Beta0.90
Volatility63.72%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.